SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹121 Cr | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr |
What is the latest Total Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹121 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹117 Cr |
| Mar2022 | ₹85 Cr |
| Mar2021 | ₹57 Cr |
How is Total Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹121 Cr | -0.20 | |
| Mar2024 | ₹122 Cr | 4.41 | |
| Mar2023 | ₹117 Cr | 37.79 | |
| Mar2022 | ₹85 Cr | 47.42 | |
| Mar2021 | ₹57 Cr | - | |
Compare Total Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹64.7 Cr | 1.8% | 0.2% | -44.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 1.8% |
0.2% |
-44.7% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses